xph stock return in 2018

The top 3 holdings of XPH are Corcept Therapeutics (CORT) (5.178%), Elanco Animal Health (ELAN) (5.129%) and Royalty Pharma  (RPRX) (4.248%).

FUND HOLDING % OF FUND VALUE ($)
XPH
Corcept Therapeutics (CORT)
5.178%
$7.7M
XPH
Elanco Animal Health (ELAN)
5.129%
$7.7M
XPH
Royalty Pharma  (RPRX)
4.248%
$6.3M
XPH
Zoetis (ZTS)
3.834%
$5.7M
XPH
Perrigo (PRGO)
3.829%
$5.7M
XPH
Eli Lilly and (LLY)
3.818%
$5.7M
XPH
Prestige Brand (PBH)
3.807%
$5.7M
XPH
Viatris (VTRS)
3.794%
$5.7M
XPH
Pfizer (PFE)
3.713%
$5.5M
XPH
Johnson & Johnson (JNJ)
3.7%
$5.5M
XPH
Axsome Therapeutics (AXSM)
3.443%
$5.1M
XPH
Merck (MRK)
3.395%
$5.1M
XPH
Tarsus Pharmaceuticals  (TARS)
3.314%
$4.9M
XPH
Jazz Pharmaceuticals (JAZZ)
3.225%
$4.8M
XPH
Bristol-Myers Squibb (BMY)
3.131%
$4.7M
XPH
Harmony Biosciences (HRMY)
3.005%
$4.5M
XPH
Pacira BioSciences (PCRX)
2.989%
$4.5M
XPH
Organon (OGN)
2.633%
$3.9M
XPH
Amphastar P (AMPH)
2.525%
$3.8M
XPH
Harrow Health (HROW)
2.314%
$3.5M
XPH
Arvinas (ARVN)
2.3%
$3.4M
XPH
Supernus Pharmaceuticals (SUPN)
2.195%
$3.3M
XPH
Edgewise Therapeutics (EWTX)
2.168%
$3.2M
XPH
ANI Pharmaceuticals (ANIP)
1.995%
$3M
XPH
Ligand Pharmaceuticals (LGND)
1.952%
$2.9M
Holdings are tracked for approximately 2000 ETFs.